Global Non-opioid Pain Patch Market Research Report 2021

Global Non-opioid Pain Patch Market Research Report 2021

Table of Contents
1 Non-opioid Pain Patch Market Overview
1.1 Product Overview and Scope of Non-opioid Pain Patch
1.2 Non-opioid Pain Patch Segment by Type
1.2.1 Global Non-opioid Pain Patch Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Lidocaine Patches
1.2.3 Diclofenac Patches
1.2.4 Methyl Salicylate Patches
1.2.5 Capsaicin Patches
1.2.6 Ketoprofen Patches
1.2.7 Others
1.3 Non-opioid Pain Patch Segment by Application
1.3.1 Non-opioid Pain Patch Sales Comparison by Application: (2021-2027)
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Independent Pharmacies & Drug Stores
1.4 Global Non-opioid Pain Patch Market Size Estimates and Forecasts
1.4.1 Global Non-opioid Pain Patch Revenue 2016-2027
1.4.2 Global Non-opioid Pain Patch Sales 2016-2027
1.4.3 Non-opioid Pain Patch Market Size by Region: 2016 Versus 2021 Versus 2027
2 Non-opioid Pain Patch Market Competition by Manufacturers
2.1 Global Non-opioid Pain Patch Sales Market Share by Manufacturers (2016-2021)
2.2 Global Non-opioid Pain Patch Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Non-opioid Pain Patch Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Non-opioid Pain Patch Manufacturing Sites, Area Served, Product Type
2.5 Non-opioid Pain Patch Market Competitive Situation and Trends
2.5.1 Non-opioid Pain Patch Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Non-opioid Pain Patch Players Market Share by Revenue
2.5.3 Global Non-opioid Pain Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Non-opioid Pain Patch Retrospective Market Scenario by Region
3.1 Global Non-opioid Pain Patch Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Non-opioid Pain Patch Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Non-opioid Pain Patch Market Facts & Figures by Country
3.3.1 North America Non-opioid Pain Patch Sales by Country
3.3.2 North America Non-opioid Pain Patch Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Non-opioid Pain Patch Market Facts & Figures by Country
3.4.1 Europe Non-opioid Pain Patch Sales by Country
3.4.2 Europe Non-opioid Pain Patch Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Non-opioid Pain Patch Market Facts & Figures by Region
3.5.1 Asia Pacific Non-opioid Pain Patch Sales by Region
3.5.2 Asia Pacific Non-opioid Pain Patch Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Non-opioid Pain Patch Market Facts & Figures by Country
3.6.1 Latin America Non-opioid Pain Patch Sales by Country
3.6.2 Latin America Non-opioid Pain Patch Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Non-opioid Pain Patch Market Facts & Figures by Country
3.7.1 Middle East and Africa Non-opioid Pain Patch Sales by Country
3.7.2 Middle East and Africa Non-opioid Pain Patch Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Non-opioid Pain Patch Historic Market Analysis by Type
4.1 Global Non-opioid Pain Patch Sales Market Share by Type (2016-2021)
4.2 Global Non-opioid Pain Patch Revenue Market Share by Type (2016-2021)
4.3 Global Non-opioid Pain Patch Price by Type (2016-2021)
5 Global Non-opioid Pain Patch Historic Market Analysis by Application
5.1 Global Non-opioid Pain Patch Sales Market Share by Application (2016-2021)
5.2 Global Non-opioid Pain Patch Revenue Market Share by Application (2016-2021)
5.3 Global Non-opioid Pain Patch Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Acorda Therapeutics
6.1.1 Acorda Therapeutics Corporation Information
6.1.2 Acorda Therapeutics Description and Business Overview
6.1.3 Acorda Therapeutics Non-opioid Pain Patch Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Acorda Therapeutics Product Portfolio
6.1.5 Acorda Therapeutics Recent Developments/Updates
6.2 ALLERGAN
6.2.1 ALLERGAN Corporation Information
6.2.2 ALLERGAN Description and Business Overview
6.2.3 ALLERGAN Non-opioid Pain Patch Sales, Revenue and Gross Margin (2016-2021)
6.2.4 ALLERGAN Product Portfolio
6.2.5 ALLERGAN Recent Developments/Updates
6.3 Endo International
6.3.1 Endo International Corporation Information
6.3.2 Endo International Description and Business Overview
6.3.3 Endo International Non-opioid Pain Patch Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Endo International Product Portfolio
6.3.5 Endo International Recent Developments/Updates
6.4 GlaxoSmithKline
6.4.1 GlaxoSmithKline Corporation Information
6.4.2 GlaxoSmithKline Description and Business Overview
6.4.3 GlaxoSmithKline Non-opioid Pain Patch Sales, Revenue and Gross Margin (2016-2021)
6.4.4 GlaxoSmithKline Product Portfolio
6.4.5 GlaxoSmithKline Recent Developments/Updates
6.5 Hisamitsu Pharmaceutical
6.5.1 Hisamitsu Pharmaceutical Corporation Information
6.5.2 Hisamitsu Pharmaceutical Description and Business Overview
6.5.3 Hisamitsu Pharmaceutical Non-opioid Pain Patch Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Hisamitsu Pharmaceutical Product Portfolio
6.5.5 Hisamitsu Pharmaceutical Recent Developments/Updates
6.6 IBSA Institut Biochimque
6.6.1 IBSA Institut Biochimque Corporation Information
6.6.2 IBSA Institut Biochimque Description and Business Overview
6.6.3 IBSA Institut Biochimque Non-opioid Pain Patch Sales, Revenue and Gross Margin (2016-2021)
6.6.4 IBSA Institut Biochimque Product Portfolio
6.6.5 IBSA Institut Biochimque Recent Developments/Updates
6.7 Mylan
6.6.1 Mylan Corporation Information
6.6.2 Mylan Description and Business Overview
6.6.3 Mylan Non-opioid Pain Patch Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Mylan Product Portfolio
6.7.5 Mylan Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Corporation Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer Non-opioid Pain Patch Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Pfizer Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 TEH SENG Pharmaceutical Mfg
6.9.1 TEH SENG Pharmaceutical Mfg Corporation Information
6.9.2 TEH SENG Pharmaceutical Mfg Description and Business Overview
6.9.3 TEH SENG Pharmaceutical Mfg Non-opioid Pain Patch Sales, Revenue and Gross Margin (2016-2021)
6.9.4 TEH SENG Pharmaceutical Mfg Product Portfolio
6.9.5 TEH SENG Pharmaceutical Mfg Recent Developments/Updates
6.10 Teikoku Seiyaku
6.10.1 Teikoku Seiyaku Corporation Information
6.10.2 Teikoku Seiyaku Description and Business Overview
6.10.3 Teikoku Seiyaku Non-opioid Pain Patch Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Teikoku Seiyaku Product Portfolio
6.10.5 Teikoku Seiyaku Recent Developments/Updates
7 Non-opioid Pain Patch Manufacturing Cost Analysis
7.1 Non-opioid Pain Patch Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Non-opioid Pain Patch
7.4 Non-opioid Pain Patch Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Non-opioid Pain Patch Distributors List
8.3 Non-opioid Pain Patch Customers
9 Non-opioid Pain Patch Market Dynamics
9.1 Non-opioid Pain Patch Industry Trends
9.2 Non-opioid Pain Patch Growth Drivers
9.3 Non-opioid Pain Patch Market Challenges
9.4 Non-opioid Pain Patch Market Restraints
10 Global Market Forecast
10.1 Non-opioid Pain Patch Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Non-opioid Pain Patch by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Non-opioid Pain Patch by Type (2022-2027)
10.2 Non-opioid Pain Patch Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Non-opioid Pain Patch by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Non-opioid Pain Patch by Application (2022-2027)
10.3 Non-opioid Pain Patch Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Non-opioid Pain Patch by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Non-opioid Pain Patch by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Non-opioid Pain Patch Sales (K MT) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Non-opioid Pain Patch Sales (K MT) Comparison by Application (2021-2027)
Table 3. Global Non-opioid Pain Patch Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Non-opioid Pain Patch Covered in This Study
Table 5. Global Non-opioid Pain Patch Sales (K MT) of Key Manufacturers (2016-2021)
Table 6. Global Non-opioid Pain Patch Sales Share by Manufacturers (2016-2021)
Table 7. Global Non-opioid Pain Patch Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Non-opioid Pain Patch Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Non-opioid Pain Patch Average Price (USD/MT) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Non-opioid Pain Patch Manufacturing Sites and Area Served
Table 11. Manufacturers Non-opioid Pain Patch Product Type
Table 12. Global Non-opioid Pain Patch Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Non-opioid Pain Patch by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-opioid Pain Patch as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Non-opioid Pain Patch Sales by Region (2016-2021) & (K MT)
Table 16. Global Non-opioid Pain Patch Sales Market Share by Region (2016-2021)
Table 17. Global Non-opioid Pain Patch Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Non-opioid Pain Patch Sales by Country (2016-2021) & (K MT)
Table 19. North America Non-opioid Pain Patch Sales Market Share by Country (2016-2021)
Table 20. North America Non-opioid Pain Patch Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Non-opioid Pain Patch Revenue Market Share by Country (2016-2021)
Table 22. Europe Non-opioid Pain Patch Sales by Country (2016-2021) & (K MT)
Table 23. Europe Non-opioid Pain Patch Sales Market Share by Country (2016-2021)
Table 24. Europe Non-opioid Pain Patch Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Non-opioid Pain Patch Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Non-opioid Pain Patch Sales by Region (2016-2021) & (K MT)
Table 27. Asia Pacific Non-opioid Pain Patch Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Non-opioid Pain Patch Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Non-opioid Pain Patch Revenue Market Share by Region (2016-2021)
Table 30. Latin America Non-opioid Pain Patch Sales by Country (2016-2021) & (K MT)
Table 31. Latin America Non-opioid Pain Patch Sales Market Share by Country (2016-2021)
Table 32. Latin America Non-opioid Pain Patch Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Non-opioid Pain Patch Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Non-opioid Pain Patch Sales by Country (2016-2021) & (K MT)
Table 35. Middle East and Africa Non-opioid Pain Patch Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Non-opioid Pain Patch Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Non-opioid Pain Patch Revenue Market Share by Country (2016-2021)
Table 38. Global Non-opioid Pain Patch Sales (K MT) by Type (2016-2021)
Table 39. Global Non-opioid Pain Patch Sales Market Share by Type (2016-2021)
Table 40. Global Non-opioid Pain Patch Revenue (Million US$) by Type (2016-2021)
Table 41. Global Non-opioid Pain Patch Revenue Share by Type (2016-2021)
Table 42. Global Non-opioid Pain Patch Price (USD/MT) by Type (2016-2021)
Table 43. Global Non-opioid Pain Patch Sales (K MT) by Application (2016-2021)
Table 44. Global Non-opioid Pain Patch Sales Market Share by Application (2016-2021)
Table 45. Global Non-opioid Pain Patch Revenue (Million US$) by Application (2016-2021)
Table 46. Global Non-opioid Pain Patch Revenue Share by Application (2016-2021)
Table 47. Global Non-opioid Pain Patch Price (USD/MT) by Application (2016-2021)
Table 48. Acorda Therapeutics Corporation Information
Table 49. Acorda Therapeutics Description and Business Overview
Table 50. Acorda Therapeutics Non-opioid Pain Patch Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 51. Acorda Therapeutics Non-opioid Pain Patch Product
Table 52. Acorda Therapeutics Recent Developments/Updates
Table 53. ALLERGAN Corporation Information
Table 54. ALLERGAN Description and Business Overview
Table 55. ALLERGAN Non-opioid Pain Patch Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 56. ALLERGAN Non-opioid Pain Patch Product
Table 57. ALLERGAN Recent Developments/Updates
Table 58. Endo International Corporation Information
Table 59. Endo International Description and Business Overview
Table 60. Endo International Non-opioid Pain Patch Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 61. Endo International Non-opioid Pain Patch Product
Table 62. Endo International Recent Developments/Updates
Table 63. GlaxoSmithKline Corporation Information
Table 64. GlaxoSmithKline Description and Business Overview
Table 65. GlaxoSmithKline Non-opioid Pain Patch Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 66. GlaxoSmithKline Non-opioid Pain Patch Product
Table 67. GlaxoSmithKline Recent Developments/Updates
Table 68. Hisamitsu Pharmaceutical Corporation Information
Table 69. Hisamitsu Pharmaceutical Description and Business Overview
Table 70. Hisamitsu Pharmaceutical Non-opioid Pain Patch Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 71. Hisamitsu Pharmaceutical Non-opioid Pain Patch Product
Table 72. Hisamitsu Pharmaceutical Recent Developments/Updates
Table 73. IBSA Institut Biochimque Corporation Information
Table 74. IBSA Institut Biochimque Description and Business Overview
Table 75. IBSA Institut Biochimque Non-opioid Pain Patch Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 76. IBSA Institut Biochimque Non-opioid Pain Patch Product
Table 77. IBSA Institut Biochimque Recent Developments/Updates
Table 78. Mylan Corporation Information
Table 79. Mylan Description and Business Overview
Table 80. Mylan Non-opioid Pain Patch Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 81. Mylan Non-opioid Pain Patch Product
Table 82. Mylan Recent Developments/Updates
Table 83. Pfizer Corporation Information
Table 84. Pfizer Description and Business Overview
Table 85. Pfizer Non-opioid Pain Patch Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 86. Pfizer Non-opioid Pain Patch Product
Table 87. Pfizer Recent Developments/Updates
Table 88. TEH SENG Pharmaceutical Mfg Corporation Information
Table 89. TEH SENG Pharmaceutical Mfg Description and Business Overview
Table 90. TEH SENG Pharmaceutical Mfg Non-opioid Pain Patch Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 91. TEH SENG Pharmaceutical Mfg Non-opioid Pain Patch Product
Table 92. TEH SENG Pharmaceutical Mfg Recent Developments/Updates
Table 93. Teikoku Seiyaku Corporation Information
Table 94. Teikoku Seiyaku Description and Business Overview
Table 95. Teikoku Seiyaku Non-opioid Pain Patch Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 96. Teikoku Seiyaku Non-opioid Pain Patch Product
Table 97. Teikoku Seiyaku Recent Developments/Updates
Table 98. Production Base and Market Concentration Rate of Raw Material
Table 99. Key Suppliers of Raw Materials
Table 100. Non-opioid Pain Patch Distributors List
Table 101. Non-opioid Pain Patch Customers List
Table 102. Non-opioid Pain Patch Market Trends
Table 103. Non-opioid Pain Patch Growth Drivers
Table 104. Non-opioid Pain Patch Market Restraints
Table 105. Global Non-opioid Pain Patch Sales Forecast by Type (2022-2027) & (K MT)
Table 106. Global Non-opioid Pain Patch Sales Market Share Forecast by Type (2022-2027)
Table 107. Global Non-opioid Pain Patch Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 108. Global Non-opioid Pain Patch Revenue Market Share Forecast by Type (2022-2027)
Table 109. Global Non-opioid Pain Patch Sales Forecast by Application (2022-2027) & (K MT)
Table 110. Global Non-opioid Pain Patch Sales Market Share Forecast by Application (2022-2027)
Table 111. Global Non-opioid Pain Patch Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 112. Global Non-opioid Pain Patch Revenue Market Share Forecast by Application (2022-2027)
Table 113. Global Non-opioid Pain Patch Sales Forecast by Region (2022-2027) & (K MT)
Table 114. Global Non-opioid Pain Patch Sales Market Share Forecast by Region (2022-2027)
Table 115. Global Non-opioid Pain Patch Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 116. Global Non-opioid Pain Patch Revenue Market Share Forecast by Region (2022-2027)
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Non-opioid Pain Patch
Figure 2. Global Non-opioid Pain Patch Market Share by Type in 2020 & 2027
Figure 3. Lidocaine Patches Product Picture
Figure 4. Diclofenac Patches Product Picture
Figure 5. Methyl Salicylate Patches Product Picture
Figure 6. Capsaicin Patches Product Picture
Figure 7. Ketoprofen Patches Product Picture
Figure 8. Others Product Picture
Figure 9. Global Non-opioid Pain Patch Market Share by Application in 2020 & 2027
Figure 10. Hospital Pharmacies
Figure 11. Online Pharmacies
Figure 12. Independent Pharmacies & Drug Stores
Figure 13. Global Non-opioid Pain Patch Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Non-opioid Pain Patch Market Size 2016-2027 (US$ Million)
Figure 15. Global Non-opioid Pain Patch Sales 2016-2027 (K MT)
Figure 16. Global Non-opioid Pain Patch Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 17. Non-opioid Pain Patch Sales Share by Manufacturers in 2020
Figure 18. Global Non-opioid Pain Patch Revenue Share by Manufacturers in 2020
Figure 19. The Global 5 and 10 Largest Non-opioid Pain Patch Players: Market Share by Revenue in 2020
Figure 20. Non-opioid Pain Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 21. Global Non-opioid Pain Patch Sales Market Share by Region (2016-2021)
Figure 22. Global Non-opioid Pain Patch Sales Market Share by Region in 2020
Figure 23. Global Non-opioid Pain Patch Revenue Market Share by Region (2016-2021)
Figure 24. Global Non-opioid Pain Patch Revenue Market Share by Region in 2020
Figure 25. U.S. Non-opioid Pain Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Canada Non-opioid Pain Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Germany Non-opioid Pain Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. France Non-opioid Pain Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. U.K. Non-opioid Pain Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Italy Non-opioid Pain Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Russia Non-opioid Pain Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. China Non-opioid Pain Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Japan Non-opioid Pain Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. South Korea Non-opioid Pain Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. India Non-opioid Pain Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Australia Non-opioid Pain Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Taiwan Non-opioid Pain Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Indonesia Non-opioid Pain Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Thailand Non-opioid Pain Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Malaysia Non-opioid Pain Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Philippines Non-opioid Pain Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Vietnam Non-opioid Pain Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Mexico Non-opioid Pain Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Brazil Non-opioid Pain Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Argentina Non-opioid Pain Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Turkey Non-opioid Pain Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Saudi Arabia Non-opioid Pain Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. U.A.E Non-opioid Pain Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Sales Market Share of Non-opioid Pain Patch by Type (2016-2021)
Figure 50. Sales Market Share of Non-opioid Pain Patch by Application (2016-2021)
Figure 51. Sales Market Share of Non-opioid Pain Patch by Application in 2020
Figure 52. Revenue Share of Non-opioid Pain Patch by Application (2016-2021)
Figure 53. Revenue Share of Non-opioid Pain Patch by Application in 2020
Figure 54. Manufacturing Cost Structure of Non-opioid Pain Patch
Figure 55. Manufacturing Process Analysis of Non-opioid Pain Patch
Figure 56. Non-opioid Pain Patch Industrial Chain Analysis
Figure 57. Channels of Distribution
Figure 58. Distributors Profiles
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs